Medimapper
ContactTest your products

GUIDED EVALUATION

Test Medimapper with your own products.

Start with a Five-Product Market Match or Portfolio Presence Scan. We review coverage first, prepare a focused proof and only then configure a three-day evaluation when it fits the workflow.

Choose your evaluation routeDownload a sample dataset

No generic demo and no unqualified self-service trial. A sample comparison of quetiapine, risperidone and olanzapine is available to download first.

A medicine product being placed into Medimapper for comparison against regional coverage and match results.

START WITH THE CURRENT QUESTION

Tell us what your team is evaluating.

01

Five-Product Market Match

For wholesalers, distributors and import-export teams.

  • You provide five products, a source market and the target regions you need to compare
  • We prepare comparable product candidates, visible pack and code differences and relevant source context

Compare 5 products →

02

Portfolio Presence Scan

For manufacturers, brands, portfolio and business-development teams.

  • You provide ten products or substances and the target regions you want to review
  • We prepare comparable presentations, packs, manufacturers, brands and product-presence patterns

Scan a portfolio →

03

API evaluation

Available from 1 October 2026.

  • For data, software and integration teams
  • Connect national records and match results to your own systems
  • Review coverage, sample responses and how production access will work

FROM PROOF TO SUBSCRIPTION

A focused evaluation with a defined result.

  1. 01

    Submit the use case

    Tell us which products, markets and decision the evaluation must support.

  2. 02

    We review coverage

    We confirm whether the required countries, fields and data depth can support a credible proof.

  3. 03

    See a product-specific proof

    We walk through a focused result using your products and markets, including relevant limitations.

  4. 04

    Agree the evaluation

    When the proof fits, we define users, access channels, success criteria and the three-day access window.

  5. 05

    Review the result

    The evaluation ends with a scheduled result call and a decision about regional subscription scope.

EVALUATION REQUEST

Tell us what you need to compare.

We use this information to review coverage and prepare the right proof. Fields marked optional can be completed during the first conversation.

The country where the organisation is registered.

The VAT, enterprise or company registration number used in that country.

A national wholesale, manufacturing or similar authorisation number, if your country issues one.

The market you would source or export from. Not required for a Portfolio Presence Scan.

Select the commercial regions you need to compare. Subscriptions are sold by region.

Add the available examples. Do not submit confidential patient or personal data. If you would rather send a product list as a file, say so here and we will reply with a secure way to share it.

For example: source-target screening, portfolio review, licensing, country prioritisation, master-data enrichment or API integration.

We review every request before offering access. Submitting this form does not automatically activate a trial.